{
  "docId": "019de074-2e24-777e-87b3-831358a7e33a",
  "docSlug": "971513439f6499291689438a6a6dd75f",
  "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 20 slides",
  "authorId": "compass-therapeutics",
  "authorName": "Compass Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 20,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 22,
  "notes": "The chart is a classic waterfall plot used in oncology clinical trials to demonstrate efficacy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2e24-777e-87b3-831358a7e33a/6",
  "deckHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a",
  "deckJsonHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a.json",
  "deckAnchorHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.827,
        "y": 0.098
      },
      "kind": "callout",
      "text": "ORR = 37.5%\nCBR = 91.5%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "accf46d5-d002-4104-98a7-24e7ecb4d89c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.62,
        "w": 0.93,
        "x": 0.035,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Waterfall plot of tumor shrinkage by patient",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5aaa6c92-a6fc-4858-9894-00b11800ede4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "disclaimer",
      "text": "2 patients were not evaluable (one missing post baseline scan; one had a scan outside of protocol window)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b534be0-3cdb-43fa-a79c-f1f0e4055b11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.1,
        "y": 0.6
      },
      "kind": "legend",
      "text": "Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder cancer, Ampullary cancer",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63327a83-c7fd-4099-94fe-2c3d1f29485f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.72,
        "x": 0.035,
        "y": 0.14
      },
      "kind": "paragraph",
      "text": "Responses achieved across multiple BTC subclasses. Data as of November 9, 2022",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0443be4f-83ec-4dcc-b9f3-8bc93c689dbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.33,
        "x": 0.035,
        "y": 0.08
      },
      "kind": "title",
      "text": "Phase 2 CTX-009 Data",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "394652c0-8970-44aa-a6fd-90da39fe69fc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "2acfdf21-6966-462d-ab44-716db14cd1ff",
      "evidence": "Waterfall plot of tumor shrinkage by patient",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "waterfall-plot",
      "slug": null,
      "matchId": "1d09359e-cddd-4c6e-958b-4e116b8535d5",
      "evidence": "Standard oncology clinical trial visualization for tumor response",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 3,
      "beatId": "d33bd1e8-59e3-4285-9fff-5d07e1436828",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Slides 3-8 detail the product, CTX-009, and its clinical trial data.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "044654bc-2486-4078-b913-f66936c4244b",
      "evidence": "Slides 6-8 present clinical trial data, implying that not investing could mean missing out on a potentially effective treatment.",
      "position": 0,
      "objective": "What are the consequences of not investing in CTX-009?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}